Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Neuroendocrine Responses to High-Intensity Reactive Exercises: Effects on Catecholamine and Hormonal Profiles in Elite U-19 Volleyball Players

14 novembre 2026 mis à jour par: Youssef Zekailiche, Mohamed Lamine Debaghine Setif 2 University

Acute Catecholamine and Glucocorticoid Responses to Reactive Speed, Agility, and Quickness Exercise in Elite U-19 Volleyball Players: A Randomized Controlled Study

The goal of this explored study intends to investigate how different types of speed, agility, and quickness (SAQ) exercises effect the body's immediate hormonal and physiological reactions in young male volleyball players. Physical exercise can alter the release of hormones and other substances involved in the body's response to physical effort and stress. However, it is still ambiguous if activities that necessitate swift reflexes to unforeseen visual stimuli provide distinct outcomes in contrast to conventional exercises that entail premeditated movements. The study will include 36 competitive male volleyball players under 19 years of age from the Algerian Amateur League. Participants will be randomly assigned to one of three groups, with 12 players in each group. The first group will conduct a 10-minute reactive training session using BlazePod, an interactive lighting system that requires participants to respond swiftly to visual inputs. The second cohort will engage in a 20-minute session with the identical approach, featuring increased workout repetitions and varied rest intervals. The third group will do 10 minutes of standard volleyball-related workouts without interactive visual indications. All participants will complete one supervised workout session. Blood samples will be collected roughly five minutes before exercise and within two minutes after exercise to assess five substances: epinephrine (adrenaline), norepinephrine (noradrenaline), dopamine, cortisol, and cortisone. These chemicals are involved in the body's responses to physical exertion and stress. Heart rate will also be recorded, and participants will report how physically challenging they found the exercises using a simple grading scale. Investigators will analyse data collected prior to and following physical activity and assess if the variations differ among the three cohorts. The study intends to better understanding of how exercise duration, physical demands, and responsiveness to visual signals may influence acute hormonal responses in young volleyball players. The results could assist researchers and sports experts in comprehending the physical requirements of reactionary exercise and inform subsequent studies on athletic training. The study is not meant to assess if these activities increase long-term sports performance. No results are currently available, and it is not yet known whether one workout strategy will create distinct hormonal reactions from another.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Réel)

36

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Sétif, Algérie
        • Mohamed Lamine Debaghine Setif 2 University.

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

17 ans à 18 ans (Enfant, Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Homme

La description

Inclusion Criteria:

  • Male volleyball players within the U-19 age category.
  • Active participation in organized competitive volleyball.
  • Sufficient physical capacity to complete the prescribed high-intensity exercise protocols.
  • Absence of musculoskeletal injury or medical conditions that could compromise safe participation.
  • Willingness to complete the experimental procedures, including pre- and post-exercise venous blood sampling.

Exclusion Criteria:

  • Current musculoskeletal injury or persistent pain affecting physical performance.
  • Diagnosed cardiovascular, metabolic, endocrine, or neurological disorders that could influence exercise tolerance or biochemical responses.
  • Use of medications or substances known to affect sympathetic nervous system activity, catecholamine secretion, or glucocorticoid regulation.
  • Inability to complete the assigned exercise protocol or blood sampling procedures.
  • Withdrawal of consent at any stage of the investigation.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Science basique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: High-Intensity Exercise Group

12 individuals are participating in high-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program.

12 participants will undergo a single high-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses.

Expérimental: Moderate-Intensity Exercise Group

12 individuals will participate in moderate-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program.

12 participants will undergo a single moderate-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses.

Aucune intervention: Control Group

12 participants will not undergo any physical intervention; instead, they will continue with their usual daily activities. Blood samples will be collected at the same time points established for the exercise groups.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Plasma Epinephrine Level
Délai: Before and immediately after the single exercise session

Plasma epinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Plasma Norepinephrine Level
Délai: Before and immediately after the single exercise session

Plasma norepinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Plasma Dopamine Level
Délai: Before and immediately after the single exercise session

Plasma dopamine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Serum Cortisol Level
Délai: Before and immediately after the single exercise session

Serum cortisol concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Serum Cortisone Level
Délai: Before and immediately after the single exercise session

Serum cortisone concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Peak Heart Rate During Exercise
Délai: During the exercise session

Peak heart rate (HRpeak) will be measured continuously during each exercise session using a heart rate monitor. HRpeak will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group.

During the exercise session
Rating of Perceived Exertion
Délai: During and immediately after the single exercise session

The Rate of Perceived Exertion (RPE) will be assessed using the Borg scale during and immediately after each exercise session. RPE values will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group.

During and immediately after the single exercise session

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: YOUSSEF ZEKAILICHE, Ph.D., Mohamed Lamine Debaghine Setif 2 University Laboratory Sciences of Physical Activities, Sports, and Public Health, Algeria.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

5 octobre 2026

Achèvement primaire (Réel)

15 octobre 2026

Achèvement de l'étude (Estimé)

5 décembre 2026

Dates d'inscription aux études

Première soumission

14 novembre 2026

Première soumission répondant aux critères de contrôle qualité

14 novembre 2026

Première publication (Réel)

19 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

19 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

14 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared to protect participant confidentiality and privacy, as this is a small single-site. Only aggregated and anonymized results will be reported.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner